These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 21056696
1. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P, Van Assche G. Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696 [Abstract] [Full Text] [Related]
2. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P. Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [Abstract] [Full Text] [Related]
3. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316 [Abstract] [Full Text] [Related]
4. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab. Bouguen G, Trouilloud I, Siproudhis L, Oussalah A, Bigard MA, Bretagne JF, Peyrin-Biroulet L. Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709 [Abstract] [Full Text] [Related]
5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [Abstract] [Full Text] [Related]
6. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease. Horsthuis K, Ziech ML, Bipat S, Spijkerboer AM, de Bruine-Dobben AC, Hommes DW, Stoker J. Clin Imaging; 2011 Sep; 35(5):360-5. PubMed ID: 21872125 [Abstract] [Full Text] [Related]
8. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753 [Abstract] [Full Text] [Related]
9. Infliximab and surgical treatment of complex anal Crohn's disease. Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ. Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707 [Abstract] [Full Text] [Related]
10. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R, Yamashita Y, Maeda K, Aoyagi K. Hepatogastroenterology; 2010 Aug; 57(97):3-7. PubMed ID: 20422862 [Abstract] [Full Text] [Related]
12. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M. Digestion; 2008 Jan; 78(4):195-200. PubMed ID: 19122456 [Abstract] [Full Text] [Related]
13. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease. Yang BL, Chen YG, Gu YF, Chen HJ, Sun GD, Zhu P, Shao WJ. World J Gastroenterol; 2015 Feb 28; 21(8):2475-82. PubMed ID: 25741157 [Abstract] [Full Text] [Related]
14. [Efficacy of infliximab combined with surgery in the treatment of perianal fistulizing Crohn disease]. Yang BL, Lin Q, Chen HJ, Sun GD, Zhu P, Chen YQ, Gu YF. Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr 28; 16(4):323-7. PubMed ID: 23608791 [Abstract] [Full Text] [Related]
16. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP. Dis Colon Rectum; 2007 Nov 28; 50(11):1754-60. PubMed ID: 17899271 [Abstract] [Full Text] [Related]
17. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q, Hogezand RA, Lamers CB, Verspaget HW. Aliment Pharmacol Ther; 2004 Sep 01; 20(5):585-92. PubMed ID: 15339330 [Abstract] [Full Text] [Related]
18. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?]. Bode M, Eder S, Schürmann G. Z Gastroenterol; 2008 Dec 01; 46(12):1376-83. PubMed ID: 19053007 [Abstract] [Full Text] [Related]
19. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG, van Gemert WG. Dis Colon Rectum; 2005 Apr 01; 48(4):758-67. PubMed ID: 15750797 [Abstract] [Full Text] [Related]
20. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Ochsenkühn T, Göke B, Sackmann M. Am J Gastroenterol; 2002 Aug 01; 97(8):2022-5. PubMed ID: 12190171 [Abstract] [Full Text] [Related] Page: [Next] [New Search]